Stock Analysis

Concerns Surrounding Alimak Group's (STO:ALIG) Performance

OM:ALIG
Source: Shutterstock

Alimak Group AB (publ)'s (STO:ALIG) robust recent earnings didn't do much to move the stock. However the statutory profit number doesn't tell the whole story, and we have found some factors which might be of concern to shareholders.

Check out our latest analysis for Alimak Group

earnings-and-revenue-history
OM:ALIG Earnings and Revenue History February 19th 2024

To understand the value of a company's earnings growth, it is imperative to consider any dilution of shareholders' interests. Alimak Group expanded the number of shares on issue by 97% over the last year. As a result, its net income is now split between a greater number of shares. To celebrate net income while ignoring dilution is like rejoicing because you have a single slice of a larger pizza, but ignoring the fact that the pizza is now cut into many more slices. You can see a chart of Alimak Group's EPS by clicking here.

How Is Dilution Impacting Alimak Group's Earnings Per Share (EPS)?

As you can see above, Alimak Group has been growing its net income over the last few years, with an annualized gain of 182% over three years. But EPS was only up 56% per year, in the exact same period. And at a glance the 37% gain in profit over the last year impresses. But earnings per share are actually down 24%, over the last twelve months. Therefore, one can observe that the dilution is having a fairly profound effect on shareholder returns.

In the long term, if Alimak Group's earnings per share can increase, then the share price should too. But on the other hand, we'd be far less excited to learn profit (but not EPS) was improving. For that reason, you could say that EPS is more important that net income in the long run, assuming the goal is to assess whether a company's share price might grow.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Alimak Group's Profit Performance

As we discussed above, Alimak Group's dilution over the last year has a major impact on its per-share earnings. For this reason, we think that Alimak Group's statutory profits may be a bad guide to its underlying earnings power, and might give investors an overly positive impression of the company. Nonetheless, it's still worth noting that its earnings per share have grown at 56% over the last three years. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So while earnings quality is important, it's equally important to consider the risks facing Alimak Group at this point in time. To help with this, we've discovered 3 warning signs (1 is concerning!) that you ought to be aware of before buying any shares in Alimak Group.

This note has only looked at a single factor that sheds light on the nature of Alimak Group's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

Valuation is complex, but we're helping make it simple.

Find out whether Alimak Group is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.